Abgent

San Diego, United States Founded: 2001 • Age: 25 yrs Acquired By WuXi AppTec
Primary antibodies are developed for research and drug discovery.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors 1 Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About Abgent

Abgent is a company based in San Diego (United States) founded in 2001 was acquired by WuXi AppTec in October 2011. Abgent operates in a competitive market with competitors including Sino Biological, GenScript, Sai Life Sciences, Mabtech and Acies Bio, among others.

  • Headquarter San Diego, United States
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Healthcare → Healthcare Services & Infrastructure Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
  • Employee Count
    Not available
  • Acquired by
    WuXi AppTec

    (Oct 13, 2011)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Abgent

Premium access

Detailed funding history for Abgent

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investors in Abgent

Abgent has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include WuXi AppTec.

All
Institutional
Investor Description Founded Year Domain Location
Provider of CRO and CDMO services
Locked Locked Locked
Premium access

Investor details for Abgent

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Abgent

Investments
Premium access

Investment portfolio details for Abgent

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Abgent

Premium access

Detailed financials for Abgent

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Abgent Comparisons

Abgent Primary company
Description
Primary antibodies are developed for research and drug disco...
Location
San Diego, United States
Founded Year
2001
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Abgent

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Abgent

Abgent operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sino Biological, GenScript, Sai Life Sciences, Mabtech and Acies Bio, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Reagents and kits are provided for clinical research applications.
Locked Locked Locked
Reagents and instruments are provided for life sciences research.
Locked Locked Locked
Complex small molecules are discovered, developed, and manufactured for pharmaceuticals.
Locked Locked Locked
Antibodies and immunoassay kits are developed for research applications.
Locked Locked Locked
Provider of drug discovery and development services to pharmaceutical, biotech, and food industries
Locked Locked Locked
Developer of antibodies for the treatment of multiple diseases
Premium access

Detailed competitors of Abgent

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Abgent

Premium access

Complete news archive for Abgent

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abgent

Abgent was founded in 2001.

Abgent is headquartered in San Diego, United States. It is registered at San Diego, California, United States.

Abgent was founded in 2001 in San Diego, United States, as a manufacturer focused on antibodies for biological research and drug discovery. A catalog of approximately 20,000 antibody products is maintained. Custom services, including antibody development, peptide synthesis, and protein expression, are provided to support research needs. The company was acquired by WuXi Apptec in October 2011, integrating its operations into broader scientific services.

Abgent's top competitors include Sai Life Sciences, Sino Biological and GenScript.

Abgent has 1 investor. Key investors include WuXi AppTec.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available